Report cover image

North America Artificial Intelligence In Cardiology Market Size, Share & Industry Analysis Report By Component, By Application, (Diagnosis, Prediction, Drug Discovery, and Other Application). By Medical Condition (Ischemic Heart Disease /CAD, Cardiac Arrh

Publisher Knowledge Based Value (KBV) Research
Published Jun 09, 2025
Length 144 Pages
SKU # KBV20173141

Description

The North America Artificial Intelligence In Cardiology Market would witness market growth of 31.7% CAGR during the forecast period (2025-2032).

The US market dominated the North America Artificial Intelligence In Cardiology Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $5,768.5 million by 2032. The Canada market is experiencing a CAGR of 35% during (2025 - 2032). Additionally, The Mexico market would exhibit a CAGR of 33.7% during (2025 - 2032).

Artificial Intelligence (AI) is reshaping the landscape of cardiology, heralding a transformative era in cardiovascular healthcare by leveraging advanced computational techniques to enhance diagnostic precision, optimize treatment strategies, and improve patient outcomes. The integration of AI into cardiology is driven by the urgent need to address the global burden of cardiovascular diseases (CVDs), which remain the leading cause of morbidity and mortality worldwide.

AI’s applications in cardiology span a wide range of clinical and research domains, revolutionizing how cardiovascular conditions are diagnosed, monitored, and treated. One of the most prominent applications is in diagnostic imaging, where AI-powered algorithms enhance the interpretation of echocardiograms, computed tomography (CT) scans, magnetic resonance imaging (MRI), and nuclear imaging. These tools analyze complex imaging data to detect conditions such as coronary artery disease (CAD), valvular heart disease, and cardiomyopathies with remarkable accuracy.

North America represents one of the most advanced and rapidly evolving markets for Artificial Intelligence (AI) in Cardiology, driven by a confluence of technological innovation, robust healthcare infrastructure, and a high prevalence of cardiovascular diseases. The region comprises major markets like the United States, Canada, and Mexico, alongside smaller but emerging markets in the Caribbean and Central America. Cardiovascular diseases remain a leading cause of death across North America, underscoring the critical need for improved diagnostic accuracy, timely interventions, and personalized treatment options.

AI technologies—including machine learning, deep learning, natural language processing, and predictive analytics—are increasingly integrated into cardiology to enhance clinical decision-making, automate image interpretation, and facilitate remote patient monitoring. The adoption of AI is supported by significant investments from both the public and private sectors, with a strong emphasis on research and development, regulatory frameworks, and collaborations between healthcare providers and technology firms. Market trends in this region focus on adoption of AI-enabled portable diagnostic devices, mobile health applications, and cloud-based platforms for cardiac data analysis.

Many healthcare providers rely on partnerships with multinational technology companies and NGOs to deploy AI solutions tailored to local needs. The competitive landscape is less saturated, offering opportunities for emerging startups and foreign technology firms to establish presence. Challenges include limited regulatory frameworks, funding constraints, and workforce shortages in both cardiology and AI specialties. Nonetheless, increasing government interest in digital transformation and healthcare modernization projects suggest a positive trajectory. Capacity building through training and knowledge exchange is a critical enabler for market growth. In conclusion, North America stands at the forefront of leveraging AI to revolutionize cardiology care, improving patient outcomes while addressing healthcare system challenges such as cost containment and specialist shortages.

Based on Component, the market is segmented into Hardware, Software, and Services. Based on Application, the market is segmented into Diagnosis, Prediction, Drug Discovery, and Other Application. Based on Medical Condition, the market is segmented into Ischemic Heart Disease /CAD, Cardiac Arrhythmias, Heart Failure, and Other Medical Condition. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • IDOVEN S.L.
  • Ultromics Ltd.
  • CardiAI.Inc.
  • Tempus AI, Inc.
  • Koninklijke Philips N.V.
  • Cleerly, Inc.
  • Vista AI, Inc.
  • Viz.ai, Inc.
  • RSIP Vision Ltd.
  • GE HealthCare Technologies, Inc.
North America Artificial Intelligence In Cardiology Market Report Segmentation

By Component
  • Hardware
  • Software
  • Services
By Application
  • Diagnosis
  • Prediction
  • Drug Discovery
  • Other Application
By Medical Condition
  • Ischemic Heart Disease /CAD
  • Cardiac Arrhythmias
  • Heart Failure
  • Other Medical Condition
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

144 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Artificial Intelligence In Cardiology Market, by Component
1.4.2 North America Artificial Intelligence In Cardiology Market, by Application
1.4.3 North America Artificial Intelligence In Cardiology Market, by Medical Condition
1.4.4 North America Artificial Intelligence In Cardiology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2024
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2021-2025)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions : 2021, Nov – 2025, Apr) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Value Chain Analysis of Artificial Intelligence In Cardiology Market
5.1 Research & Development (R&D):
5.2 Data Acquisition & Management:
5.3 Model Development & Training:
5.4 Regulatory Approval & Certification:
5.5 Product Integration & Deployment:
5.6 Marketing & Sales:
5.7 After-Sales Support & Feedback Loop:
Chapter 6. Key Customer Criteria - Artificial Intelligence In Cardiology Market
6.1 Diagnostic Accuracy
6.2 Regulatory Compliance
6.3 Data Privacy and Security
6.4 Integration with Existing Healthcare Systems
6.5 Clinical Validation and Peer-Reviewed Evidence
6.6 Ease of Use and Interface Design
6.7 Real-Time Processing and Speed
6.8 Cost-Effectiveness and Return on Investment (ROI)
6.9 Continuous Learning and Model Updates
6.10. Vendor Support and Training Services
Chapter 7. North America Artificial Intelligence In Cardiology Market by Component
7.1 North America Hardware Market by Country
7.2 North America Software Market by Country
7.3 North America Services Market by Country
Chapter 8. North America Artificial Intelligence In Cardiology Market by Application
8.1 North America Diagnosis Market by Country
8.2 North America Prediction Market by Country
8.3 North America Drug Discovery Market by Country
8.4 North America Other Application Market by Country
Chapter 9. North America Artificial Intelligence In Cardiology Market by Medical Condition
9.1 North America Ischemic Heart Disease /CAD Market by Country
9.2 North America Cardiac Arrhythmias Market by Country
9.3 North America Heart Failure Market by Country
9.4 North America Other Medical Condition Market by Country
Chapter 10. North America Artificial Intelligence In Cardiology Market by Country
10.1 US Artificial Intelligence In Cardiology Market
10.1.1 US Artificial Intelligence In Cardiology Market by Component
10.1.2 US Artificial Intelligence In Cardiology Market by Application
10.1.3 US Artificial Intelligence In Cardiology Market by Medical Condition
10.2 Canada Artificial Intelligence In Cardiology Market
10.2.1 Canada Artificial Intelligence In Cardiology Market by Component
10.2.2 Canada Artificial Intelligence In Cardiology Market by Application
10.2.3 Canada Artificial Intelligence In Cardiology Market by Medical Condition
10.3 Mexico Artificial Intelligence In Cardiology Market
10.3.1 Mexico Artificial Intelligence In Cardiology Market by Component
10.3.2 Mexico Artificial Intelligence In Cardiology Market by Application
10.3.3 Mexico Artificial Intelligence In Cardiology Market by Medical Condition
10.4 Rest of North America Artificial Intelligence In Cardiology Market
10.4.1 Rest of North America Artificial Intelligence In Cardiology Market by Component
10.4.2 Rest of North America Artificial Intelligence In Cardiology Market by Application
10.4.3 Rest of North America Artificial Intelligence In Cardiology Market by Medical Condition
Chapter 11. Company Profiles
11.1 IDOVEN S.L.
11.1.1 Company Overview
11.2 Ultromics Ltd.
11.2.1 Company Overview
11.2.2 Recent strategies and developments:
11.2.2.1 Partnerships, Collaborations, and Agreements:
11.2.2.2 Product Launches and Product Expansions:
11.3 CardiAI Inc.
11.3.1 Company Overview
11.4 Tempus AI, Inc.
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Research & Development Expenses
11.4.4 Recent strategies and developments:
11.4.4.1 Product Launches and Product Expansions:
11.4.4.2 Acquisition and Mergers:
11.4.5 SWOT Analysis
11.5 Koninklijke Philips N.V.
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Product Launches and Product Expansions:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 Cleerly, Inc.
11.6.1 Company Overview
11.6.2 Recent strategies and developments:
11.6.2.1 Partnerships, Collaborations, and Agreements:
11.7 Vista AI, Inc.
11.7.1 Company Overview
11.8 Viz.ai, Inc.
11.8.1 Company Overview
11.8.2 Recent strategies and developments:
11.8.2.1 Partnerships, Collaborations, and Agreements:
11.8.2.2 Product Launches and Product Expansions:
11.9 RSIP Vision Ltd.
11.9.1 Company Overview
11.10. GE HealthCare Technologies, Inc.
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Segmental and Regional Analysis
11.10.4 Research & Development Expenses
11.10.5 Recent strategies and developments:
11.10.5.1 Product Launches and Product Expansions:
11.10.6 SWOT Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us